Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 468461 - 468480 out of 483419 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
USA | (L01CD02) docetaxel | DOCIVYX 10MG/ML INJ,CONC | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvyxaPharma,LLC |
USA | (L01CD02) docetaxel | DOCIVYX 10MG/ML INJ,CONC | 8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvyxaPharma,LLC |
USA | (L01CD02) docetaxel | DOCIVYX 10MG/ML INJ,CONC | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvyxaPharma,LLC |
USA | (L01EB01) gefitinib (adm: O) | GEFITINIB 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
USA | (L01EB09) lazertinib | LAZCLUZE 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01EB09) lazertinib | LAZCLUZE 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
USA | (L01FD01) trastuzumab | ONTRUZANT 150MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | OrganonLLC |
USA | (L01XX05) hydroxycarbamide | HYDROXYUREA 500MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PSORIASIS- | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PSORIASIS- | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |